vs
艾里逊变速箱控股公司（ALSN）与Pediatrix Medical Group, Inc.（MD）财务数据对比。点击上方公司名可切换其他公司
艾里逊变速箱控股公司的季度营收约是Pediatrix Medical Group, Inc.的1.5倍（$737.0M vs $493.8M），艾里逊变速箱控股公司净利率更高（13.4% vs 6.8%，领先6.6%），Pediatrix Medical Group, Inc.同比增速更快（-1.7% vs -7.4%），过去两年Pediatrix Medical Group, Inc.的营收复合增速更高（-0.1% vs -3.4%）
艾里逊变速箱控股公司是美国商用自动变速箱及混合动力推进系统生产商，产品获全球250余家整车厂商指定采用，广泛应用于公交、环卫、消防、工程建设、物流配送、军工等多个领域及特种作业场景。
Pediatrix Medical Group是美国领先的专科医疗服务提供商，核心业务覆盖母胎医学、新生儿科、儿科心脏病学等儿科亚专科领域，与美国各地医疗机构合作，为女性、新生儿及儿童提供循证专科医疗服务。
ALSN vs MD — 直观对比
营收规模更大
ALSN
是对方的1.5倍
$493.8M
营收增速更快
MD
高出5.7%
-7.4%
净利率更高
ALSN
高出6.6%
6.8%
两年增速更快
MD
近两年复合增速
-3.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $737.0M | $493.8M |
| 净利润 | $99.0M | $33.7M |
| 毛利率 | 48.0% | — |
| 营业利润率 | 23.2% | 9.9% |
| 净利率 | 13.4% | 6.8% |
| 营收同比 | -7.4% | -1.7% |
| 净利润同比 | -43.4% | 10.5% |
| 每股收益（稀释后） | $1.18 | $0.40 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ALSNMD
| Q4 25 | $737.0M | $493.8M | ||
| Q3 25 | $693.0M | $492.9M | ||
| Q2 25 | $814.0M | $468.8M | ||
| Q1 25 | $766.0M | $458.4M | ||
| Q4 24 | $796.0M | $502.4M | ||
| Q3 24 | $824.0M | $511.2M | ||
| Q2 24 | $816.0M | $504.3M | ||
| Q1 24 | $789.0M | $495.1M |
净利润ALSNMD
| Q4 25 | $99.0M | $33.7M | ||
| Q3 25 | $137.0M | $71.7M | ||
| Q2 25 | $195.0M | $39.3M | ||
| Q1 25 | $192.0M | $20.7M | ||
| Q4 24 | $175.0M | $30.5M | ||
| Q3 24 | $200.0M | $19.4M | ||
| Q2 24 | $187.0M | $-153.0M | ||
| Q1 24 | $169.0M | $4.0M |
毛利率ALSNMD
| Q4 25 | 48.0% | — | ||
| Q3 25 | 47.5% | — | ||
| Q2 25 | 49.4% | — | ||
| Q1 25 | 49.3% | — | ||
| Q4 24 | 46.9% | — | ||
| Q3 24 | 48.1% | — | ||
| Q2 24 | 48.3% | — | ||
| Q1 24 | 46.4% | — |
营业利润率ALSNMD
| Q4 25 | 23.2% | 9.9% | ||
| Q3 25 | 29.4% | 13.8% | ||
| Q2 25 | 31.4% | 12.8% | ||
| Q1 25 | 32.5% | 7.0% | ||
| Q4 24 | 29.5% | 7.8% | ||
| Q3 24 | 31.6% | 6.6% | ||
| Q2 24 | 32.2% | -31.3% | ||
| Q1 24 | 29.7% | 3.2% |
净利率ALSNMD
| Q4 25 | 13.4% | 6.8% | ||
| Q3 25 | 19.8% | 14.5% | ||
| Q2 25 | 24.0% | 8.4% | ||
| Q1 25 | 25.1% | 4.5% | ||
| Q4 24 | 22.0% | 6.1% | ||
| Q3 24 | 24.3% | 3.8% | ||
| Q2 24 | 22.9% | -30.3% | ||
| Q1 24 | 21.4% | 0.8% |
每股收益（稀释后）ALSNMD
| Q4 25 | $1.18 | $0.40 | ||
| Q3 25 | $1.63 | $0.84 | ||
| Q2 25 | $2.29 | $0.46 | ||
| Q1 25 | $2.23 | $0.24 | ||
| Q4 24 | $2.01 | $0.37 | ||
| Q3 24 | $2.27 | $0.23 | ||
| Q2 24 | $2.13 | $-1.84 | ||
| Q1 24 | $1.90 | $0.05 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.5B | $375.2M |
| 总债务越低越好 | $2.9B | $570.5M |
| 股东权益账面价值 | $1.9B | $865.9M |
| 总资产 | $6.1B | $2.2B |
| 负债/权益比越低杠杆越低 | 1.56× | 0.66× |
8季度趋势，按日历期对齐
现金及短期投资ALSNMD
| Q4 25 | $1.5B | $375.2M | ||
| Q3 25 | $902.0M | $340.1M | ||
| Q2 25 | $778.0M | $224.7M | ||
| Q1 25 | $753.0M | $99.0M | ||
| Q4 24 | $781.0M | $229.9M | ||
| Q3 24 | $788.0M | $103.8M | ||
| Q2 24 | $648.0M | $19.4M | ||
| Q1 24 | $551.0M | $8.0M |
总债务ALSNMD
| Q4 25 | $2.9B | $570.5M | ||
| Q3 25 | $2.4B | $577.2M | ||
| Q2 25 | $2.4B | $583.9M | ||
| Q1 25 | $2.4B | $590.5M | ||
| Q4 24 | $2.4B | $597.1M | ||
| Q3 24 | $2.4B | — | ||
| Q2 24 | $2.4B | — | ||
| Q1 24 | $2.4B | — |
股东权益ALSNMD
| Q4 25 | $1.9B | $865.9M | ||
| Q3 25 | $1.8B | $890.7M | ||
| Q2 25 | $1.8B | $833.8M | ||
| Q1 25 | $1.7B | $789.2M | ||
| Q4 24 | $1.7B | $764.9M | ||
| Q3 24 | $1.6B | $732.5M | ||
| Q2 24 | $1.5B | $706.5M | ||
| Q1 24 | $1.3B | $856.2M |
总资产ALSNMD
| Q4 25 | $6.1B | $2.2B | ||
| Q3 25 | $5.5B | $2.2B | ||
| Q2 25 | $5.4B | $2.1B | ||
| Q1 25 | $5.4B | $2.0B | ||
| Q4 24 | $5.3B | $2.2B | ||
| Q3 24 | $5.4B | $2.1B | ||
| Q2 24 | $5.2B | $2.0B | ||
| Q1 24 | $5.1B | $2.2B |
负债/权益比ALSNMD
| Q4 25 | 1.56× | 0.66× | ||
| Q3 25 | 1.31× | 0.65× | ||
| Q2 25 | 1.38× | 0.70× | ||
| Q1 25 | 1.45× | 0.75× | ||
| Q4 24 | 1.46× | 0.78× | ||
| Q3 24 | 1.49× | — | ||
| Q2 24 | 1.63× | — | ||
| Q1 24 | 1.80× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $243.0M | $114.1M |
| 自由现金流经营现金流 - 资本支出 | $169.0M | — |
| 自由现金流率自由现金流/营收 | 22.9% | — |
| 资本支出强度资本支出/营收 | 10.0% | — |
| 现金转化率经营现金流/净利润 | 2.45× | 3.39× |
| 过去12个月自由现金流最近4个季度 | $661.0M | — |
8季度趋势，按日历期对齐
经营现金流ALSNMD
| Q4 25 | $243.0M | $114.1M | ||
| Q3 25 | $228.0M | $137.3M | ||
| Q2 25 | $184.0M | $137.2M | ||
| Q1 25 | $181.0M | $-117.5M | ||
| Q4 24 | $211.0M | $133.0M | ||
| Q3 24 | $246.0M | $91.8M | ||
| Q2 24 | $171.0M | $107.0M | ||
| Q1 24 | $173.0M | $-125.2M |
自由现金流ALSNMD
| Q4 25 | $169.0M | — | ||
| Q3 25 | $184.0M | — | ||
| Q2 25 | $153.0M | — | ||
| Q1 25 | $155.0M | — | ||
| Q4 24 | $136.0M | — | ||
| Q3 24 | $210.0M | — | ||
| Q2 24 | $150.0M | — | ||
| Q1 24 | $162.0M | — |
自由现金流率ALSNMD
| Q4 25 | 22.9% | — | ||
| Q3 25 | 26.6% | — | ||
| Q2 25 | 18.8% | — | ||
| Q1 25 | 20.2% | — | ||
| Q4 24 | 17.1% | — | ||
| Q3 24 | 25.5% | — | ||
| Q2 24 | 18.4% | — | ||
| Q1 24 | 20.5% | — |
资本支出强度ALSNMD
| Q4 25 | 10.0% | — | ||
| Q3 25 | 6.3% | — | ||
| Q2 25 | 3.8% | — | ||
| Q1 25 | 3.4% | — | ||
| Q4 24 | 9.4% | — | ||
| Q3 24 | 4.4% | — | ||
| Q2 24 | 2.6% | — | ||
| Q1 24 | 1.4% | — |
现金转化率ALSNMD
| Q4 25 | 2.45× | 3.39× | ||
| Q3 25 | 1.66× | 1.91× | ||
| Q2 25 | 0.94× | 3.49× | ||
| Q1 25 | 0.94× | -5.66× | ||
| Q4 24 | 1.21× | 4.36× | ||
| Q3 24 | 1.23× | 4.72× | ||
| Q2 24 | 0.91× | — | ||
| Q1 24 | 1.02× | -31.03× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ALSN
| North America On Highway | $361.0M | 49% |
| Service Parts Support Equipment And Other | $160.0M | 22% |
| Outside North America On Highway | $131.0M | 18% |
| Defense | $73.0M | 10% |
| Global Off-Highway | $12.0M | 2% |
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
